FDA inspection
Amicogen (China) Biopharm Co., Ltd.: FDA inspection ending Aug 30, 2024
FDA inspection 1249683 · Voluntary Action Indicated (VAI) · Jining
Key facts
| Inspection ID | 1249683 |
|---|---|
| Firm | Amicogen (China) Biopharm Co., Ltd. |
| FEI number | 3013147895 |
| Address | 1688 Shixian Road, Ren Cheng |
| City | Jining |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Aug 30, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| Product type | Veterinary |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data